Double Medical Technology

Double Medical Technology EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Double Medical Technology (002901.SZ) as of Oct 12, 2026 is 719.07 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 467.67 M CNY — a change of 53.76% (higher).

EBITDA

719.07 MCNY

YoY

53.76%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Double Medical Technology is 2025 719.07 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Double Medical Technology was 2024 467.67 M CNY. It decreases by 53.76% higher compared to the previous year.

The Double Medical Technology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
453.09 M CNY
Jan 1, 2019
583.70 M CNY
Jan 1, 2020
730.44 M CNY
Jan 1, 2021
847.88 M CNY
Jan 1, 2022
180.70 M CNY
Jan 1, 2023
138.77 M CNY
Jan 1, 2024
467.67 M CNY
Jan 1, 2025
719.07 M CNY
The Double Medical Technology EBITDA history
YEAREBITDAYoY
719.07 MCNY+53.76%
467.67 MCNY+237.01%
138.77 MCNY-23.20%
180.70 MCNY-78.69%
847.88 MCNY+16.08%
730.44 MCNY+25.14%
583.70 MCNY+28.83%
453.09 MCNY+25.46%
361.13 MCNY+42.98%
252.57 MCNY+14.30%
220.97 MCNY+33.29%
165.78 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Double Medical Technology Stock analysis

What does Double Medical Technology do? Double Medical Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Double Medical Technology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Double Medical Technology is 719.07 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Double Medical Technology changed from 467.67 M CNY to 719.07 M CNY, representing a 53.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Double Medical Technology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Double Medical Technology historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Double Medical Technology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Double Medical Technology